- Positron Emission Tomography (PET) Scanner, Single Photon Emission Computed Tomography (SPECT) Scanner,
- Gamma Camera,
- Nuclear Magnetic Resonance (NMR) Spectrometer,
- Magnetic Resonance Spectroscopy,
- Optical Imaging,
- Molecular Ultrasound Imaging,
- Others
Molecular Imaging Market size was valued at USD 4,425.3 million in 2022 and is expected to reach a value of USD 6,437.4 million by 2029, growing at a CAGR of 5.5% from 2023-29. The global market provides a detailed overview of the molecular imaging market that can be segmented by device type, application, and end user. By device type, the molecular imaging market has been segmented into Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Scanner, Gamma Cameras, Nuclear Magnetic Resonance (NMR) Spectrometers, Magnetic Resonance Spectroscopy, Optical Imaging, Molecular Ultrasound Imaging and Others. The Positron Emission Tomography (PET) Scanner segment is likely to be the largest and fastest-growing segment in terms of device type. Based on application, the molecular imaging market is segmented into cardiovascular, neurology, respiratory, oncology, gastrointestinal disorders, and others. Among these, the cardiovascular segment is expected to have the fastest-growing market during the forecast period. On the basis of end users, the market is segregated into hospitals, ambulatory surgical centers, diagnostic imaging centers, and others. The hospitals held a considerable market share during the forecast period.
Molecular Imaging Market Summary
Study Period
2023-29
Base Year
2022
CAGR
0.055%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Molecular Imaging Market Dynamics
Rising demand for accurate and reliable imaging systems for more accurate and detailed disease diagnosis, rising frequency of numerous chronic diseases, and ongoing development and innovation in molecular imaging technologies are some key factors fostering the market growth.
Asia-Pacific Got Significant Share Of
Molecular Imaging Market Regional Analysis
By region, the Asia Pacific market is expected to witness the highest market share during the forecast period. The prevalence of chronic diseases, urbanization, the aging population, and the need for better diagnostic treatment are all likely to contribute to the region's growth. North America held a considerable market share during the estimated period due to a surge in healthcare funding from public and commercial organizations for the creation of technologically sophisticated medical systems to meet the demands of a growing population suffering from various ailments.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Molecular Imaging Market Segmentation
By Device type
By Application
- Cardiovascular,
- Neurology,
- Respiratory,
- Oncology,
- Gastrointestinal Disorder,
- Others
By End User
- Hospitals,
- Ambulatory Surgical Centers,
- Diagnostic Imaging Centers,
- Others
Frequently Asked Questions
The molecular imaging market size was valued at USD 4,425.3 million in 2022
The molecular imaging market key players are: Hitachi Medical Corporation (Japan) Siemens Healthineers (Germany) Toshiba Medical Systems (Japan) GE Healthcare (UK) Philips Healthcare (Netherlands) Esaote SpA (Italy) Sanrad Medical Systems Pvt. Ltd (India) Aurora Imaging Technology, Inc. (U.S.) SUMEC Group Corporation (China) Positron Corporation (U.S.)
The molecular imaging market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1.Executive Summary |
| 2. Global Molecular Imaging Market Introduction |
| 2.1.Global Molecular Imaging Market - Taxonomy |
| 2.2.Global Molecular Imaging Market - Definitions |
| 2.2.1.Device type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3. Global Molecular Imaging Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID-19 on Market |
| 4. Global Molecular Imaging Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Molecular Imaging Market By Device Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Positron Emission Tomography (PET) Scanner, Single Photon Emission Computed Tomography (SPECT) Scanner, |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Gamma Camera, |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Nuclear Magnetic Resonance (NMR) Spectrometer, |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Magnetic Resonance Spectroscopy, |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Optical Imaging, |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Molecular Ultrasound Imaging, |
| 5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Others |
| 5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 6. Global Molecular Imaging Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Cardiovascular, |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Neurology, |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Respiratory, |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Oncology, |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Gastrointestinal Disorder, |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7. Global Molecular Imaging Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Hospitals, |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ambulatory Surgical Centers, |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diagnostic Imaging Centers, |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Molecular Imaging Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Molecular Imaging Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Device Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Positron Emission Tomography (PET) Scanner, Single Photon Emission Computed Tomography (SPECT) Scanner, |
| 9.1.2.Gamma Camera, |
| 9.1.3.Nuclear Magnetic Resonance (NMR) Spectrometer, |
| 9.1.4.Magnetic Resonance Spectroscopy, |
| 9.1.5.Optical Imaging, |
| 9.1.6.Molecular Ultrasound Imaging, |
| 9.1.7.Others |
| 9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Cardiovascular, |
| 9.2.2.Neurology, |
| 9.2.3.Respiratory, |
| 9.2.4.Oncology, |
| 9.2.5.Gastrointestinal Disorder, |
| 9.2.6.Others |
| 9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals, |
| 9.3.2.Ambulatory Surgical Centers, |
| 9.3.3.Diagnostic Imaging Centers, |
| 9.3.4.Others |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Molecular Imaging Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Device type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Positron Emission Tomography (PET) Scanner, Single Photon Emission Computed Tomography (SPECT) Scanner, |
| 10.1.2.Gamma Camera, |
| 10.1.3.Nuclear Magnetic Resonance (NMR) Spectrometer, |
| 10.1.4.Magnetic Resonance Spectroscopy, |
| 10.1.5.Optical Imaging, |
| 10.1.6.Molecular Ultrasound Imaging, |
| 10.1.7.Others |
| 10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Cardiovascular, |
| 10.2.2.Neurology, |
| 10.2.3.Respiratory, |
| 10.2.4.Oncology, |
| 10.2.5.Gastrointestinal Disorder, |
| 10.2.6.Others |
| 10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals, |
| 10.3.2.Ambulatory Surgical Centers, |
| 10.3.3.Diagnostic Imaging Centers, |
| 10.3.4.Others |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Molecular Imaging Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Device type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Positron Emission Tomography (PET) Scanner, Single Photon Emission Computed Tomography (SPECT) Scanner, |
| 11.1.2.Gamma Camera, |
| 11.1.3.Nuclear Magnetic Resonance (NMR) Spectrometer, |
| 11.1.4.Magnetic Resonance Spectroscopy, |
| 11.1.5.Optical Imaging, |
| 11.1.6.Molecular Ultrasound Imaging, |
| 11.1.7.Others |
| 11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Cardiovascular, |
| 11.2.2.Neurology, |
| 11.2.3.Respiratory, |
| 11.2.4.Oncology, |
| 11.2.5.Gastrointestinal Disorder, |
| 11.2.6.Others |
| 11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals, |
| 11.3.2.Ambulatory Surgical Centers, |
| 11.3.3.Diagnostic Imaging Centers, |
| 11.3.4.Others |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Molecular Imaging Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Device type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Positron Emission Tomography (PET) Scanner, Single Photon Emission Computed Tomography (SPECT) Scanner, |
| 12.1.2.Gamma Camera, |
| 12.1.3.Nuclear Magnetic Resonance (NMR) Spectrometer, |
| 12.1.4.Magnetic Resonance Spectroscopy, |
| 12.1.5.Optical Imaging, |
| 12.1.6.Molecular Ultrasound Imaging, |
| 12.1.7.Others |
| 12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Cardiovascular, |
| 12.2.2.Neurology, |
| 12.2.3.Respiratory, |
| 12.2.4.Oncology, |
| 12.2.5.Gastrointestinal Disorder, |
| 12.2.6.Others |
| 12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals, |
| 12.3.2.Ambulatory Surgical Centers, |
| 12.3.3.Diagnostic Imaging Centers, |
| 12.3.4.Others |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Molecular Imaging Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Device type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Positron Emission Tomography (PET) Scanner, Single Photon Emission Computed Tomography (SPECT) Scanner, |
| 13.1.2.Gamma Camera, |
| 13.1.3.Nuclear Magnetic Resonance (NMR) Spectrometer, |
| 13.1.4.Magnetic Resonance Spectroscopy, |
| 13.1.5.Optical Imaging, |
| 13.1.6.Molecular Ultrasound Imaging, |
| 13.1.7.Others |
| 13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Cardiovascular, |
| 13.2.2.Neurology, |
| 13.2.3.Respiratory, |
| 13.2.4.Oncology, |
| 13.2.5.Gastrointestinal Disorder, |
| 13.2.6.Others |
| 13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals, |
| 13.3.2.Ambulatory Surgical Centers, |
| 13.3.3.Diagnostic Imaging Centers, |
| 13.3.4.Others |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M&A, Strategies, and SWOT Analysis) |
| 14.2.1.Hitachi Medical Corporation (Japan) |
| 14.2.2.Siemens Healthineers (Germany) |
| 14.2.3.Toshiba Medical Systems (Japan) |
| 14.2.4.GE Healthcare (UK) |
| 14.2.5.Philips Healthcare (Netherlands) |
| 14.2.6.Esaote SpA (Italy) |
| 14.2.7.Sanrad Medical Systems Pvt. Ltd (India) |
| 14.2.8.Aurora Imaging Technology, Inc. (U.S.) |
| 14.2.9.SUMEC Group Corporation (China) |
| 14.2.10.Positron Corporation (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Hitachi Medical Corporation (Japan)
- Siemens Healthineers (Germany)
- Toshiba Medical Systems (Japan)
- GE Healthcare (UK)
- Philips Healthcare (Netherlands)
- Esaote SpA (Italy)
- Sanrad Medical Systems Pvt. Ltd (India)
- Aurora Imaging Technology, Inc. (U.S.)
- SUMEC Group Corporation (China)
- Positron Corporation (U.S.)